Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Mitoxantrone

An anticancer drug of the anthracenedione class, related to the anthracyclines, approved in 1987 and used against certain leukaemias; it is also used in some forms of multiple sclerosis. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.

Did you know?It can turn the urine blue-green for about 24 hours after administration and sometimes give the whites of the eyes a temporary bluish tint.

MitoxantroneGo to the active ingredient →
MitoxantroneActive ingredientMitoxantroneCat. No. P-M150-001CAS 65271-80-9

EDQM standards 2

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.